Release Date: 30/09/14 18:57 Summary: Notice of General Meeting/Proxy Form Price Sensitive: No Download Document 164.46KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%